Aeluma, Inc. insider Jonathan Klamkin reported a sale of company common stock on July 1, 2026, according to a Form 4 filed July 2. The transaction involved 19,900 shares of Aeluma common stock sold at a weighted average price of $21.081 per share. The filing states that the shares were sold in multiple transactions at prices ranging from $20.54 to $21.52 per share. Based on the weighted average price, the sale had an approximate value of $419,512. The reported transaction code was a sale of common stock, and the filing notes that Klamkin will provide detailed price-by-price information upon request to the SEC staff, the company, or a security holder. The sale was made pursuant to a Rule 10b5-1 trading plan adopted by Klamkin on December 3, 2025. Such plans allow insiders to schedule trades in advance under preset conditions, which can help address concerns about trading on material nonpublic information. After the July 1 transaction, Klamkin beneficially owned 2,503 shares of Aeluma common stock directly. The filing was signed on July 2, 2026, by Joshua L. Colburn as attorney-in-fact for the reporting person.